Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

Authors:
Douglas E. Wood
Search for other papers by Douglas E. Wood in
Current site
Google Scholar
PubMed
Close
 MD
,
Ella A. Kazerooni
Search for other papers by Ella A. Kazerooni in
Current site
Google Scholar
PubMed
Close
 MD
,
Scott L. Baum
Search for other papers by Scott L. Baum in
Current site
Google Scholar
PubMed
Close
 MD
,
George A. Eapen
Search for other papers by George A. Eapen in
Current site
Google Scholar
PubMed
Close
 MD
,
David S. Ettinger
Search for other papers by David S. Ettinger in
Current site
Google Scholar
PubMed
Close
 MD
,
Lifang Hou
Search for other papers by Lifang Hou in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
David M. Jackman
Search for other papers by David M. Jackman in
Current site
Google Scholar
PubMed
Close
 MD
,
Donald Klippenstein
Search for other papers by Donald Klippenstein in
Current site
Google Scholar
PubMed
Close
 MD
,
Rohit Kumar
Search for other papers by Rohit Kumar in
Current site
Google Scholar
PubMed
Close
 MD
,
Rudy P. Lackner
Search for other papers by Rudy P. Lackner in
Current site
Google Scholar
PubMed
Close
 MD
,
Lorriana E. Leard
Search for other papers by Lorriana E. Leard in
Current site
Google Scholar
PubMed
Close
 MD
,
Inga T. Lennes
Search for other papers by Inga T. Lennes in
Current site
Google Scholar
PubMed
Close
 MD, MPH, MBA
,
Ann N.C. Leung
Search for other papers by Ann N.C. Leung in
Current site
Google Scholar
PubMed
Close
 MD
,
Samir S. Makani
Search for other papers by Samir S. Makani in
Current site
Google Scholar
PubMed
Close
 MD
,
Pierre P. Massion
Search for other papers by Pierre P. Massion in
Current site
Google Scholar
PubMed
Close
 MD
,
Peter Mazzone
Search for other papers by Peter Mazzone in
Current site
Google Scholar
PubMed
Close
 MD, MPH
,
Robert E. Merritt
Search for other papers by Robert E. Merritt in
Current site
Google Scholar
PubMed
Close
 MD
,
Bryan F. Meyers
Search for other papers by Bryan F. Meyers in
Current site
Google Scholar
PubMed
Close
 MD, MPH
,
David E. Midthun
Search for other papers by David E. Midthun in
Current site
Google Scholar
PubMed
Close
 MD
,
Sudhakar Pipavath
Search for other papers by Sudhakar Pipavath in
Current site
Google Scholar
PubMed
Close
 MD
,
Christie Pratt
Search for other papers by Christie Pratt in
Current site
Google Scholar
PubMed
Close
 DHSc, MA
,
Chakravarthy Reddy
Search for other papers by Chakravarthy Reddy in
Current site
Google Scholar
PubMed
Close
 MD
,
Mary E. Reid
Search for other papers by Mary E. Reid in
Current site
Google Scholar
PubMed
Close
 PhD
,
Arnold J. Rotter
Search for other papers by Arnold J. Rotter in
Current site
Google Scholar
PubMed
Close
 MD
,
Peter B. Sachs
Search for other papers by Peter B. Sachs in
Current site
Google Scholar
PubMed
Close
 MD
,
Matthew B. Schabath
Search for other papers by Matthew B. Schabath in
Current site
Google Scholar
PubMed
Close
 PhD
,
Mark L. Schiebler
Search for other papers by Mark L. Schiebler in
Current site
Google Scholar
PubMed
Close
 MD
,
Betty C. Tong
Search for other papers by Betty C. Tong in
Current site
Google Scholar
PubMed
Close
 MD, MHS
,
William D. Travis
Search for other papers by William D. Travis in
Current site
Google Scholar
PubMed
Close
 MD
,
Benjamin Wei
Search for other papers by Benjamin Wei in
Current site
Google Scholar
PubMed
Close
 MD
,
Stephen C. Yang
Search for other papers by Stephen C. Yang in
Current site
Google Scholar
PubMed
Close
 MD
,
Kristina M. Gregory
Search for other papers by Kristina M. Gregory in
Current site
Google Scholar
PubMed
Close
 RN, MSN, OCN
, and
Miranda Hughes
Search for other papers by Miranda Hughes in
Current site
Google Scholar
PubMed
Close
 PhD
Restricted access

Lung cancer is the leading cause of cancer-related mortality in the United States and worldwide. Early detection of lung cancer is an important opportunity for decreasing mortality. Data support using low-dose computed tomography (LDCT) of the chest to screen select patients who are at high risk for lung cancer. Lung screening is covered under the Affordable Care Act for individuals with high-risk factors. The Centers for Medicare & Medicaid Services (CMS) covers annual screening LDCT for appropriate Medicare beneficiaries at high risk for lung cancer if they also receive counseling and participate in shared decision-making before screening. The complete version of the NCCN Guidelines for Lung Cancer Screening provides recommendations for initial and subsequent LDCT screening and provides more detail about LDCT screening. This manuscript focuses on identifying patients at high risk for lung cancer who are candidates for LDCT of the chest and on evaluating initial screening findings.

  • Collapse
  • Expand
  • 1.

    Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev 2016;25:1627.

  • 2.

    Torre LA, Bray F, Siegel RL et al.. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87108.

  • 3.

    The Health Consequences of Smoking: A Report of the Surgeon General (ed 2010/07/30). Atlanta: US Department of Health and Human Services; 2004.

  • 4.

    Thun MJ, Henley SJ, Burns D et al.. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006;98:691699.

  • 5.

    Jemal A, Bray F, Center MM et al.. Global cancer statistics. CA Cancer J Clin 2011;61:6990.

  • 6.

    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:730.

  • 7.

    Howlader N, Noone AM, Krapcho M et al.. SEER Cancer Statistics Review, 1975–2014, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Bethesda, MD: National Cancer Institute; 2017.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Jemal A, Ward EM, Johnson CJ et al.. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst 2017;109.

  • 9.

    Jemal A, Thun MJ, Ries LA et al.. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008;100:16721694.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    National Lung Screening Trial Research Team Aberle DR, Berg CD et al.. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243253.

  • 11.

    National Lung Screening Trial Research Team Aberle DR, Adams AM et al.. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395409.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Aberle DR, DeMello S, Berg CD et al.. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013;369:920931.

  • 13.

    National Lung Screening Trial Research Team Church TR, Black WC et al.. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013;368:19801991.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Kramer BS, Berg CD, Aberle DR, Prorok PC. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). J Med Screen 2011;18:109111.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Midthun DE. Screening for lung cancer. Clin Chest Med 2011;32:659668.

  • 16.

    Moyer VAForce USPST. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330338.

  • 17.

    Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e78S92S.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Wood DE, Eapen GA, Ettinger DS et al.. Lung cancer screening. J Natl Compr Canc Netw 2012;10:240265.

  • 19.

    Wood DE. Lung cancer screening: the last 10 years. J Natl Compr Canc Netw 2012;10:13231325.

  • 20.

    Kazerooni EA, Armstrong MR, Amorosa JK et al.. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol 2016;13:R3034.

  • 21.

    McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol 2016;13:R2529.

  • 22.

    Pinsky PF, Gierada DS, Black W et al.. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med 2015;162:485491.

  • 23.

    Leone FT, Evers-Casey S, Toll BA, Vachani A. Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e61S77S.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Fucito LM, Czabafy S, Hendricks PS et al.. Pairing smoking-cessation services with lung cancer screening: a clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer 2016;122:11501159.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Sitas F, Weber MF, Egger S, Yap S, Chiew M, O'Connell D. Smoking cessation after cancer. J Clin Oncol 2014;32:35933595.

  • 26.

    Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer 2007;56:125134.

  • 27.

    Cataldo JK, Dubey S, Prochaska JJ. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010;78:289301.

  • 28.

    Hays JT, McFadden DD, Ebbert JO. Pharmacologic agents for tobacco dependence treatment: 2011 update. Curr Atheroscler Rep 2012;14:8592.

  • 29.

    Wiener RS, Gould MK, Arenberg DA et al.. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med 2015;192:881891.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Mazzone P, Powell CA, Arenberg D et al.. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest 2015;147:295303.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31.

    Davis AM, Cifu AS. Lung cancer screening. JAMA 2014;312:12481249.

  • 32.

    Fintelmann FJ, Bernheim A, Digumarthy SR et al.. The 10 pillars of lung cancer screening: rationale and logistics of a lung cancer screening program. Radiographics 2015;35:18931908.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    Armstrong K, Kim JJ, Halm EA et al.. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer 2016;122:13381342.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34.

    Kazerooni EA, Austin JH, Black WC et al.. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J Thorac Imaging 2014;29:310316.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    McKee BJ, Regis SM, McKee AB et al.. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol 2015;12:273276.

  • 36.

    de Koning HJ, Meza R, Plevritis SK et al.. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:311320.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37.

    Wiener RS, Gould MK, Woloshin S et al.. What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest. 2013;143:672677.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Aberle DR, Abtin F, Brown K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol 2013;31:10021008.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Goulart BH, Ramsey SD. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs. Oncologist 2013;18:941946.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Sox HC. Implementing lung cancer screening under Medicare: the last chance to get it right? JAMA 2014;312:12061207.

  • 41.

    Volk RJ, Hawk E, Bevers TB. Should CMS cover lung cancer screening for the fully informed patient? JAMA 2014;312:11931194.

  • 42.

    Field JK, Smith RA, Aberle DR et al.. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol 2012;7:1019.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43.

    Bach PB, Mirkin JN, Oliver TK et al.. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:24182429.

  • 44.

    Walter JE, Heuvelmans MA, de Jong PA et al.. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016;17:907916.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45.

    Field JK, Duffy SW, Baldwin DR et al.. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess 2016;20:1146.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46.

    Field JK, Duffy SW, Baldwin DR et al.. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016;71:161170.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47.

    Patz EF Jr., Greco E, Gatsonis C et al.. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 2016;17:590599.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Wille MM, Dirksen A, Ashraf H et al.. Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. Am J Respir Crit Care Med 2016;193:542551.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49.

    Horeweg N, van Rosmalen J, Heuvelmans MA et al.. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:13321341.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50.

    Horeweg N, Scholten ET, de Jong PA et al.. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014;15:13421350.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51.

    Prosch H, Schaefer-Prokop C. Screening for lung cancer. Curr Opin Oncol 2014;26:131137.

  • 52.

    Horeweg N, van der Aalst CM, Thunnissen E et al.. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013;187:848854.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53.

    McRonald FE, Yadegarfar G, Baldwin DR et al.. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) 2014;7:362371.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54.

    Field JK, van Klaveren R, Pedersen JH et al.. European randomized lung cancer screening trials: post NLST. J Surg Oncol 2013;108:280286.

  • 55.

    Ru Zhao Y, Xie X, de Koning HJ et al.. NELSON lung cancer screening study. Cancer Imaging 2011;11 Spec No A:S7984.

  • 56.

    Xu DM, Gietema H, de Koning H et al.. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177184.

  • 57.

    Nair A, Hansell DM. European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol 2011;21:24452454.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58.

    van Iersel CA, de Koning HJ, Draisma G et al.. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868874.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59.

    Patz EF Jr., Pinsky P, Gatsonis C et al.. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014;174:269274.

  • 60.

    Reich JM. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening. Thorax 2008;63:377383.

  • 61.

    Black WC. Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer 2007;110:23702384.

  • 62.

    Oken MM, Hocking WG, Kvale PA et al.. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306:18651873.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 63.

    Wender R, Fontham ET, Barrera E Jr. et al.. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107117.

  • 64.

    Jaklitsch MT, Jacobson FL, Austin JH et al.. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:3338.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65.

    Roberts H, Walker-Dilks C, Sivjee K et al.. Screening high-risk populations for lung cancer: guideline recommendations. J Thorac Oncol 2013;8:12321237.

  • 66.

    Alberg AJ, Brock MV, Ford JG et al.. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e1S29S.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67.

    Driscoll T, Nelson DI, Steenland K et al.. The global burden of disease due to occupational carcinogens. Am J Ind Med 2005;48:419431.

  • 68.

    de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am 2012;50:863876.

  • 69.

    Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol 2008;3:819831.

  • 70.

    Jamal A, King BA, Neff LJ et al.. Current cigarette smoking among adults - United States, 2005-2015. MMWR Morb Mortal Wkly Rep 2016;65:12051211.

  • 71.

    Jacobs EJ, Newton CC, Carter BD et al.. What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking? Ann Epidemiol 2015;25:179182 e171.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 72.

    Centers for Disease Control and Prevention. Current cigarette smoking among adults—United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61:889894.

  • 73.

    Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med 2014;370:6068.

  • 74.

    Chen LS, Baker T, Hung RJ et al.. Genetic risk can be decreased: quitting smoking decreases and delays lung cancer for smokers with high and low CHRNA5 risk genotypes - a meta-analysis. EBioMedicine 2016;11:219226.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 75.

    Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:11941210.

  • 76.

    Secretan B, Straif K, Baan R et al.. A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;10:10331034.

  • 77.

    Sakoda LC, Loomis MM, Doherty JA et al.. Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. Int J Mol Epidemiol Genet 2012;3:117.

  • 78.

    Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008;57:12261228.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 79.

    Jha P, Ramasundarahettige C, Landsman V et al.. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341350.

  • 80.

    Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519.

  • 81.

    Moolgavkar SH, Holford TR, Levy DT et al.. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst 2012;104:541548.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 82.

    Peto R, Darby S, Deo H et al.. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321:323329.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 83.

    Kasza KA, Ambrose BK, Conway KP et al.. Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med 2017;376:342353.

  • 84.

    Hu SS, Neff L, Agaku IT et al.. Tobacco product use among adults - United States, 2013-2014. MMWR Morb Mortal Wkly Rep 2016;65:685691.

  • 85.

    Office on Smoking and Health (US). The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General (ed 2010/07/30). Atlanta: Centers for Disease Control and Prevention; 2006.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 86.

    Garfinkel L. Time trends in lung cancer mortality among nonsmokers and a note on passive smoking. J Natl Cancer Inst 1981;66:10611066.

  • 87.

    Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997;315:980988.

  • 88.

    Delva F, Margery J, Laurent F et al.. Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations. BMC Public Health 2017;17:191.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 89.

    Straif K, Benbrahim-Tallaa L, Baan R et al.. A review of human carcinogens--part C: metals, arsenic, dusts, and fibres. Lancet Oncol 2009;10:453454.

  • 90.

    Silverman DT, Samanic CM, Lubin JH et al.. The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst 2012;104:855868.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 91.

    Nelson DI, Concha-Barrientos M, Driscoll T et al.. The global burden of selected occupational diseases and injury risks: methodology and summary. Am J Ind Med 2005;48:400418.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 92.

    Nurminen M, Karjalainen A. Epidemiologic estimate of the proportion of fatalities related to occupational factors in Finland. Scand J Work Environ Health 2001;27:161213.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 93.

    Steenland K, Loomis D, Shy C, Simonsen N. Review of occupational lung carcinogens. Am J Ind Med 1996;29:474490.

  • 94.

    Markowitz SB, Levin SM, Miller A, Morabia A. Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. Am J Respir Crit Care Med 2013;188:9096.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 95.

    Frost G, Darnton A, Harding AH. The effect of smoking on the risk of lung cancer mortality for asbestos workers in Great Britain (1971-2005). Ann Occup Hyg 2011;55:239247.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 96.

    Reid A, de Klerk NH, Ambrosini GL et al.. The risk of lung cancer with increasing time since ceasing exposure to asbestos and quitting smoking. Occup Environ Med 2006;63:509512.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 97.

    El Ghissassi F, Baan R, Straif K et al.. A review of human carcinogens--part D: radiation. Lancet Oncol 2009;10:751752.

  • 98.

    Leuraud K, Schnelzer M, Tomasek L et al.. Radon, smoking and lung cancer risk: results of a joint analysis of three European case-control studies among uranium miners. Radiat Res 2011;176:375387.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 99.

    Lubin JH & Boice JD Jr. Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst 1997;89:4957.

  • 100.

    Darby S, Hill D, Auvinen A et al.. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ 2005;330:223.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 101.

    Wu GX, Nelson RA, Kim JY, Raz DJ. Non-small cell lung cancer as a second primary among patients with previous malignancy: who is at risk? Clin Lung Cancer 2017;18:543550.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 102.

    Tucker MA, Murray N, Shaw EG et al.. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst 1997;89:17821788.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 103.

    Shiels MS, Gibson T, Sampson J et al.. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol 2014;32:39893995.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 104.

    Travis LB, Gospodarowicz M, Curtis RE et al.. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002;94:182192.

  • 105.

    Morris LG, Sikora AG, Patel SG et al.. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol 2011;29:739746.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 106.

    Kawaguchi T, Matsumura A, Iuchi K et al.. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy. Jpn J Clin Oncol 2006;36:711.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 107.

    Richardson GE, Tucker MA, Venzon DJ et al.. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993;119:383390.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 108.

    Jonsson S, Thorsteinsdottir U, Gudbjartsson DF et al.. Familial risk of lung carcinoma in the Icelandic population. JAMA 2004;292:29772983.

  • 109.

    Li X, Hemminki K. Familial multiple primary lung cancers: a population-based analysis from Sweden. Lung Cancer 2005;47:301307.

  • 110.

    Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 2005;93:825833.

  • 111.

    Bailey-Wilson JE, Amos CI, Pinney SM et al.. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004;75:460474.

  • 112.

    Thorgeirsson TE, Geller F, Sulem P et al.. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638642.

  • 113.

    Hung RJ, McKay JD, Gaborieau V et al.. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633637.

  • 114.

    Amos CI, Wu X, Broderick P et al.. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616622.

  • 115.

    Yang IA, Holloway JW, Fong KM. Genetic susceptibility to lung cancer and co-morbidities. J Thorac Dis 2013;5 Suppl 5:S454462.

  • 116.

    Hwang SJ, Cheng LS, Lozano G et al.. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet 2003;113:238243.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 117.

    Sanders BM, Jay M, Draper GJ, Roberts EM. Non-ocular cancer in relatives of retinoblastoma patients. Br J Cancer 1989;60:358365.

  • 118.

    Fletcher O, Easton D, Anderson K et al.. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004;96:357363.

  • 119.

    Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999;149:1320.

  • 120.

    Samet JM, Humble CG, Pathak DR. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 1986;134:466470.

  • 121.

    Alavanja MC, Brownson RC, Boice JD Jr., Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 1992;136:623632.

  • 122.

    Wu-Williams AH, Dai XD, Blot W et al.. Lung cancer among women in north-east China. Br J Cancer 1990;62:982987.

  • 123.

    Gao YT, Blot WJ, Zheng W et al.. Lung cancer among Chinese women. Int J Cancer 1987;40:604609.

  • 124.

    Brenner AV, Wang Z, Kleinerman RA et al.. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol 2001;30:118124.

  • 125.

    Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease: a prospective, matched, controlled study. Ann Intern Med 1986;105:503507.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 126.

    Yang P, Sun Z, Krowka MJ et al.. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 2008;168:10971103.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 127.

    Lowry KP, Gazelle GS, Gilmore ME et al.. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: a decision analysis. Cancer 2015;121:15561562.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 128.

    Young RP, Hopkins RJ. How the genetics of lung cancer may overlap with COPD. Respirology 2011;16:10471055.

  • 129.

    El-Zein RA, Young RP, Hopkins RJ, Etzel CJ. Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk. Cancer Prev Res (Phila) 2012;5:522527.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 130.

    Koshiol J, Rotunno M, Consonni D et al.. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 2009;4:e7380.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 131.

    Young RP, Hopkins RJ, Christmas T et al.. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009;34:380386.

  • 132.

    Turner MC, Chen Y, Krewski D et al.. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007;176:285290.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 133.

    Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980;35:496499.

  • 134.

    Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study. Am J Respir Crit Care Med 2000;161:58.

  • 135.

    Hughes JM, Weill H. Asbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality study. Br J Ind Med 1991;48:229233.

  • 136.

    Han SS, Ten Haaf K, Hazelton WD et al.. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. Int J Cancer 2017;140:24362443.

  • 137.

    McKee BJ, Hashim JA, French RJ et al.. Experience with a CT screening program for individuals at high risk for developing lung cancer. J Am Coll Radiol 2015;12:192197.

  • 138.

    Kovalchik SA, Tammemagi M, Berg CD et al.. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245254.

  • 139.

    Berg CD. Formidable challenges ahead for lung cancer screening. Oncology (Williston Park) 2012;26:182, 185.

  • 140.

    Pinsky PF, Berg CD. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen 2012;19:154156.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 141.

    Pinsky PF, Kramer BS. Lung cancer risk and demographic characteristics of current 20-29 pack-year smokers: implications for screening. J Natl Cancer Inst 2015;107.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 142.

    Miller DL, Mayfield WR, Luu TD et al.. Community-based multidisciplinary computed tomography screening program improves lung cancer survival. Ann Thorac Surg 2016;101:18641869.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 143.

    Katki HA, Kovalchik SA, Berg CD et al.. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA 2016;315:23002311.

  • 144.

    Li K, Husing A, Sookthai D et al.. Selecting high-risk individuals for lung cancer screening: a prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort. Cancer Prev Res (Phila) 2015;8:777785.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 145.

    Tammemagi MC, Church TR, Hocking WG et al.. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014;11:e1001764.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 146.

    Ten Haaf K, Jeon J, Tammemagi MC et al.. Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study. PLoS Med 2017;14:e1002277.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 147.

    Yousaf-Khan U, van der Aalst C, de Jong PA et al.. Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax 2017;72:819824.

  • 148.

    Saghir Z, Dirksen A, Ashraf H et al.. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296301.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 149.

    Pedersen JH, Ashraf H, Dirksen A et al.. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. J Thorac Oncol 2009;4:608614.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 150.

    Menezes RJ, Roberts HC, Paul NS et al.. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer 2010;67:177183.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 151.

    Swensen SJ, Jett JR, Hartman TE et al.. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259265.

  • 152.

    Wilson DO, Weissfeld JL, Fuhrman CR et al.. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008;178:956961.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 153.

    Pinsky PF, Gierada DS, Hocking W et al.. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med 2014;161:627633.

  • 154.

    Varlotto JM, Decamp MM, Flickinger JC et al.. Would screening for lung cancer benefit 75- to 84-year-old residents of the United States? Front Oncol 2014;4:37.

  • 155.

    Sox HC. Better evidence about screening for lung cancer. N Engl J Med 2011;365:455457.

  • 156.

    Jett JR, Midthun DE. Screening for lung cancer: for patients at increased risk for lung cancer, it works. Ann Intern Med 2011;155:540542.

  • 157.

    Berrington de Gonzalez A, Kim KP, Berg CD. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen 2008;15:153158.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 158.

    Marshall HM, Bowman RV, Yang IA et al.. Screening for lung cancer with low-dose computed tomography: a review of current status. J Thorac Dis 2013;5 Suppl 5:S524539.

  • 159.

    Yip R, Henschke CI, Xu DM et al.. Lung cancers manifesting as part-solid nodules in the National Lung Screening Trial. AJR Am J Roentgenol 2017;208:10111021.

  • 160.

    Gardiner N, Jogai S, Wallis A. The revised lung adenocarcinoma classification-an imaging guide. J Thorac Dis 2014;6:S537546.

  • 161.

    Naidich DP, Bankier AA, MacMahon H et al.. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266:304317.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 162.

    Seidelman JL, Myers JL, Quint LE. Incidental, subsolid pulmonary nodules at CT: etiology and management. Cancer Imaging 2013;13:365373.

  • 163.

    Hansell DM, Bankier AA, MacMahon H et al.. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246:697722.

  • 164.

    Travis WD, Asamura H, Bankier AA et al.. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2016;11:12041223.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 165.

    Travis WD, Brambilla E, Noguchi M et al.. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 2013;137:668684.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 166.

    Travis WD, Brambilla E, Noguchi M et al.. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244285.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 167.

    Kim HY, Shim YM, Lee KS et al.. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology 2007;245:267275.

  • 168.

    Yip R, Yankelevitz DF, Hu M et al.. Lung cancer deaths in the National Lung Screening Trial attributed to nonsolid nodules. Radiology 2016;281:589596.

  • 169.

    Fukui M, Suzuki K, Matsunaga T et al.. Surgical intervention for ground glass dominant lesions: observation or outright resection? Jpn J Clin Oncol 2017:16.

  • 170.

    Gould MK, Donington J, Lynch WR et al.. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e93S120S.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 171.

    Chang B, Hwang JH, Choi YH et al.. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 2013;143:172178.

  • 172.

    Lindell RM, Hartman TE, Swensen SJ et al.. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007;242:555562.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 173.

    MacMahon H, Austin JH, Gamsu G et al.. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395400.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 174.

    Jacobs C, van Rikxoort EM, Murphy K et al.. Computer-aided detection of pulmonary nodules: a comparative study using the public LIDC/IDRI database. Eur Radiol 2016;26:21392147.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 175.

    Zhao Y, de Bock GH, Vliegenthart R et al.. Performance of computer-aided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume. Eur Radiol 2012;22:20762084.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 176.

    Armato SG 3rd, McLennan G, Bidaut L et al.. The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans. Med Phys 2011;38:915931.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 177.

    Clark TJ, Flood TF, Maximin ST, Sachs PB. Lung CT screening reporting and data system speed and accuracy are increased with the use of a semiautomated computer application. J Am Coll Radiol 2015;12:f13011306.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 178.

    Jacobs C, van Rikxoort EM, Scholten ET et al.. Solid, part-solid, or non-solid?: classification of pulmonary nodules in low-dose chest computed tomography by a computer-aided diagnosis system. Invest Radiol 2015;50:168173.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 179.

    Valencia R, Denecke T, Lehmkuhl L et al.. Value of axial and coronal maximum intensity projection (MIP) images in the detection of pulmonary nodules by multislice spiral CT: comparison with axial 1-mm and 5-mm slices. Eur Radiol 2006;16:325332.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 180.

    Fischbach F, Knollmann F, Griesshaber V et al.. Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol 2003;13:23782383.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 181.

    Kawel N, Seifert B, Luetolf M, Boehm T. Effect of slab thickness on the CT detection of pulmonary nodules: use of sliding thin-slab maximum intensity projection and volume rendering. AJR Am J Roentgenol 2009;192:13241329.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 182.

    Peloschek P, Sailer J, Weber M et al.. Pulmonary nodules: sensitivity of maximum intensity projection versus that of volume rendering of 3D multidetector CT data. Radiology 2007;243:561569.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 183.

    Park EA, Goo JM, Lee JW et al.. Efficacy of computer-aided detection system and thin-slab maximum intensity projection technique in the detection of pulmonary nodules in patients with resected metastases. Invest Radiol 2009;44:105113.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 184.

    Jankowski A, Martinelli T, Timsit JF et al.. Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection. Eur Radiol 2007;17:31483156.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 185.

    Rubin GD, Lyo JK, Paik DS et al.. Pulmonary nodules on multi-detector row CT scans: performance comparison of radiologists and computer-aided detection. Radiology 2005;234:274283.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 186.

    Fraioli F, Bertoletti L, Napoli A et al.. Computer-aided detection (CAD) in lung cancer screening at chest MDCT: ROC analysis of CAD versus radiologist performance. J Thorac Imaging 2007;22:241246.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 187.

    Sahiner B, Chan HP, Hadjiiski LM et al.. Effect of CAD on radiologists' detection of lung nodules on thoracic CT scans: analysis of an observer performance study by nodule size. Acad Radiol 2009;16:15181530.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 188.

    Das M, Muhlenbruch G, Heinen S et al.. Performance evaluation of a computer-aided detection algorithm for solid pulmonary nodules in low-dose and standard-dose MDCT chest examinations and its influence on radiologists. Br J Radiol 2008;81:841847.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 189.

    Lee HY, Goo JM, Lee HJ et al.. Usefulness of concurrent reading using thin-section and thick-section CT images in subcentimetre solitary pulmonary nodules. Clin Radiol 2009;64:127132.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 190.

    Kubo T, Lin PJ, Stiller W et al.. Radiation dose reduction in chest CT: a review. AJR Am J Roentgenol 2008;190:335343.

  • 191.

    Lee JY, Chung MJ, Yi CA, Lee KS. Ultra-low-dose MDCT of the chest: influence on automated lung nodule detection. Korean J Radiol 2008;9:95101.

  • 192.

    Funama Y, Awai K, Liu D et al.. Detection of nodules showing ground-glass opacity in the lungs at low-dose multidetector computed tomography: phantom and clinical study. J Comput Assist Tomogr 2009;33:4953.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 193.

    Hein PA, Romano VC, Rogalla P et al.. Linear and volume measurements of pulmonary nodules at different CT dose levels - intrascan and interscan analysis. Rofo 2009;181:2431.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 194.

    van Riel SJ, Sanchez CI, Bankier AA et al.. Observer variability for classification of pulmonary nodules on low-dose CT images and its effect on nodule management. Radiology 2015;277:863871.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 195.

    Ridge CA, Yildirim A, Boiselle PM et al.. Differentiating between subsolid and solid pulmonary nodules at CT: inter- and intraobserver agreement between experienced thoracic radiologists. Radiology 2016;278:888896.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 196.

    Kim H, Park CM, Song YS et al.. Measurement variability of persistent pulmonary subsolid nodules on same-day repeat CT: what is the threshold to determine true nodule growth during follow-up? PLoS One 2016;11:e0148853.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 197.

    Penn A, Ma M, Chou BB et al.. Inter-reader variability when applying the 2013 Fleischner guidelines for potential solitary subsolid lung nodules. Acta Radiol 2015;56:11801186.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 198.

    Pinsky PF, Gierada DS, Nath PH et al.. National lung screening trial: variability in nodule detection rates in chest CT studies. Radiology 2013;268:865873.

  • 199.

    Singh S, Pinsky P, Fineberg NS et al.. Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Radiology 2011;259:263270.

  • 200.

    Gierada DS, Pilgram TK, Ford M et al.. Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening. Radiology 2008;246:265272.

  • 201.

    Henschke CI, Boffetta P, Gorlova O et al.. Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer 2011;71:328332.

  • 202.

    van Klaveren RJ, Oudkerk M, Prokop M et al.. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:22212229.

  • 203.

    Lopes Pegna A, Picozzi G, Mascalchi M et al.. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:3440.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 204.

    Veronesi G, Bellomi M, Scanagatta P et al.. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg 2008;136:611617.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 205.

    Infante M, Cavuto S, Lutman FR et al.. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009;180:445453.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 206.

    Swensen SJ, Jett JR, Hartman TE et al.. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003;226:756761.

  • 207.

    Henschke CI, Yankelevitz DF, Naidich DP et al.. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164168.

  • 208.

    Henschke CI, Yankelevitz DF, Miettinen OSInternational Early Lung Cancer Action Program Investigators. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med 2006;166:321325.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 209.

    International Early Lung Cancer Action Program Investigators Henschke CI, Yankelevitz DF et al.. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:17631771.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 210.

    Steele JD, Buell P. Asymptomatic solitary pulmonary nodules. Host survival, tumor size, and growth rate. J Thorac Cardiovasc Surg 1973;65:140151.

  • 211.

    Galante E, Reduzzi D, Gallus G et al.. The growth rate in the interpretation of the natural history of lung cancer. Tumori 1984;70:427432.

  • 212.

    Usuda K, Saito Y, Sagawa M et al.. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer 1994;74:22392244.

  • 213.

    Arai T, Kuroishi T, Saito Y et al.. Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group. Jpn J Clin Oncol 1994;24:199204.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 214.

    Weiss W, Boucot KR, Cooper DA. The histopathology of bronchogenic carcinoma and its relation to growth rate, metastasis, and prognosis. Cancer 1970;26:965970.

  • 215.

    Patel VK, Naik SK, Naidich DP et al.. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm. Chest 2013;143:840846.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 216.

    Murrmann GB, van Vollenhoven FH, Moodley L. Approach to a solid solitary pulmonary nodule in two different settings-”Common is common, rare is rare”. J Thorac Dis 2014;6:237248.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 217.

    Allen TL, Kendi AT, Mitiek MO, Maddaus MA. Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer. Semin Thorac Cardiovasc Surg 2011;23:4350.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 218.

    Swensen SJ, Viggiano RW, Midthun DE et al.. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214:7380.

  • 219.

    Yi CA, Lee KS, Kim BT et al.. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med 2006;47:443450.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 220.

    Christensen JA, Nathan MA, Mullan BP et al.. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol 2006;187:13611367.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 221.

    Schillaci O, Travascio L, Bolacchi F et al.. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients. Radiol Med 2009;114:890906.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 222.

    Bastarrika G, Garcia-Velloso MJ, Lozano MD et al.. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005;171:13781383.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 223.

    Sebro R, Aparici CM, Hernandez-Pampaloni M. FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease. Ann Nucl Med 2013;27:400405.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 224.

    Reyes N, Onadeko OO, Luraschi-Monjagatta Mdel C et al.. Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region. Lung 2014;192:589593.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 225.

    Huber H, Hodolic M, Stelzmuller I et al.. Malignant disease as an incidental finding at (1)(8)F-FDG-PET/CT scanning in patients with granulomatous lung disease. Nucl Med Commun 2015;36:430437.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 226.

    McWilliams A, Tammemagi MC, Mayo JR et al.. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910919.

  • 227.

    Herder GJ, van Tinteren H, Golding RP et al.. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005;128:24902496.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 228.

    Patel VK, Naik SK, Naidich DP et al.. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest 2013;143:825839.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 229.

    Gould MK, Fletcher J, Iannettoni MD et al.. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:108S130S.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 230.

    Madsen PH, Holdgaard PC, Christensen JB, Hoilund-Carlsen PF. Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer. Eur J Nucl Med Mol Imaging 2016;43:20842097.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 231.

    Al-Ameri A, Malhotra P, Thygesen H et al.. Risk of malignancy in pulmonary nodules: a validation study of four prediction models. Lung Cancer 2015;89:2730.

  • 232.

    Infante M, Cavuto S, Lutman FR et al.. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 2015;191:11661175.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 233.

    Gierada DS, Pinsky P, Nath H et al.. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst 2014;106.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 234.

    Yip R, Henschke CI, Yankelevitz DF, Smith JP. CT screening for lung cancer: alternative definitions of positive test result based on the National Lung Screening Trial and International Early Lung Cancer Action Program databases. Radiology 2014;273:591596.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 235.

    Wood DE, Kazerooni E, Baum SL et al.. Lung cancer screening, version 1.2015: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2015;13:2334; quiz 34.

  • 236.

    Kazerooni EA, Armstrong MR, Amorosa JK et al.. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol 2015;12:3842.

  • 237.

    Henschke CI, Yip R, Yankelevitz DF, Smith JPInternational Early Lung Cancer Action Program Investigators. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013;158:246252.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 238.

    Revel MP, Bissery A, Bienvenu M et al.. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology 2004;231:453458.

  • 239.

    Rampinelli C, Origgi D, Bellomi M. Low-dose CT: technique, reading methods and image interpretation. Cancer Imaging 2013;12:548556.

  • 240.

    Donnelly EF. Technical parameters and interpretive issues in screening computed tomography scans for lung cancer. J Thorac Imaging 2012;27:224229.

  • 241.

    Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e369S399S.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 242.

    Kim H, Park CM, Koh